Post by Tanveer Ahmad
🌟 TANVEER AHMAD Personal Branding Statement A results-driven pharmaceutical leader with deep expertise in SALES, MARKETING, and DISTRIBUTION MANAGEMENT, 36 Year Exp
bject: Feasibility of Establishing an IVF / ICSI / FET Center in Pakistan Prepared By: Tanveer Ahmad Based on the current healthcare landscape in Pakistan, the establishment of a modern IVF, ICSI, and Frozen Embryo Transfer (FET) center presents a promising investment opportunity. The increasing prevalence of infertility, delayed marriages, lifestyle-related reproductive disorders, and growing awareness of assisted reproductive technologies have significantly expanded the demand for fertility services across the country. A professionally managed fertility center equipped with modern laboratory facilities and staffed by qualified fertility consultants and embryologists can achieve sustainable growth and profitability. While the initial capital investment may range between PKR 90 million and 180 million, the expected return on investment is attractive due to the high demand for fertility treatments and the relatively limited number of specialized centers available. The success of such a project depends primarily on: Recruitment of experienced fertility specialists and embryologists. Compliance with international laboratory and quality standards. Strategic location selection in major urban centers. Effective patient counseling and service excellence. Strong ethical and professional practices. Based on current market trends, a center performing 20–30 IVF/ICSI cycles per month can achieve operational sustainability and recover its investment within approximately 1.5 to 3 years, subject to effective management and clinical outcomes. In conclusion, the establishment of an IVF/ICSI/FET center in Pakistan is considered both medically valuable and commercially viable. Investors with a long-term vision, commitment to quality healthcare, and access to qualified clinical professionals are likely to achieve favorable financial and social outcomes through this venture. Prepared by: Tanveer Ahmad Consultant – Healthcare, Pharmaceutical Sales & Marketing June 2026